Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization (2019 - 2025)

Eton Pharmaceuticals' Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $446000.0 for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 12.91% year-over-year to $446000.0; the TTM value through Dec 2024 reached $446000.0, up 12.91%, while the annual FY2024 figure was $446000.0, 12.91% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $446000.0 at Eton Pharmaceuticals, up from $422000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $519000.0 in Q2 2020 and bottomed at $14000.0 in Q3 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $155000.0 (2021), against an average of $227866.7.
  • The largest annual shift saw Accumulated Depreciation & Amortization plummeted 95.38% in 2021 before it surged 1638.1% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $347000.0 in 2020, then tumbled by 55.33% to $155000.0 in 2021, then tumbled by 57.42% to $66000.0 in 2022, then soared by 498.48% to $395000.0 in 2023, then increased by 12.91% to $446000.0 in 2024.
  • Per Business Quant, the three most recent readings for ETON's Accumulated Depreciation & Amortization are $446000.0 (Q4 2024), $422000.0 (Q2 2024), and $410000.0 (Q1 2024).